首页> 外文期刊>Microvascular Research: An International Journal >Aqueous extract of the medicinal plant Patrinia villosa Juss. Induces angiogenesis via activation of focal adhesion kinase.
【24h】

Aqueous extract of the medicinal plant Patrinia villosa Juss. Induces angiogenesis via activation of focal adhesion kinase.

机译:药用植物败酱草(Patrinia villosa Juss)的水提取物。通过激活粘着斑激酶诱导血管生成。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Patrinia villosa, a Chinese medicinal herb, is known for its anti-inflammatory effects. In the present study, we tested the pro-angiogenic efficacy of an aqueous extract of Patrinia villosa (PVE) in vitro and in vivo. Treatment with PVE significantly enhanced cell proliferation, migration, and the capillary-like structure forming activity of cultured human umbilical vein endothelial cells (HUVECs). Western blot analysis demonstrated that PVE treatment induced a time-dependent phosphorylation of FAK and Akt in HUVECs. Preincubation with a FAK inhibitor, SC203950, abolished PVE-induced proliferation of HUVECs, indicating a role for FAK in PVE-induced angiogenesis. The proangiogenic activity of PVE was confirmed by an ex vivo mouse aortic ring assay and an in vivo murine hindlimb ischemia model. Further analysis using fractions of PVE partitioned by n-hexane, EtOAc, n-BuOH, and water residue revealed that the EtOAc fraction contains the bioactive components responsible for PVE-induced migration, endothelial cord formation, FAK phosphorylation, and aortic ring sprouting. Our results provide a rationale for the use of PVE in the treatment of peripheral vascular insufficiency; they indicate the need to identify the novel pro-angiogenic chemicals in the fractions of PVE.
机译:广香(Patrinia villosa)是一种中草药,具有抗炎作用。在本研究中,我们在体外和体内测试了Patrinia villosa(PVE)水提取物的促血管生成功效。 PVE处理可显着增强培养的人脐静脉内皮细胞(HUVEC)的细胞增殖,迁移和毛细管样结构形成活性。蛋白质印迹分析表明,PVE处理可诱导HUVEC中FAK和Akt的时间依赖性磷酸化。与FAK抑制剂SC203950的预孵育消除了PVE诱导的HUVEC增殖,表明FAK在PVE诱导的血管生成中起作用。通过离体小鼠主动脉环测定和体内鼠后肢缺血模型证实了PVE的促血管生成活性。使用由正己烷,EtOAc,n-BuOH和水残留物分配的PVE馏分进行的进一步分析显示,EtOAc馏分包含负责PVE诱导的迁移,内皮索形成,FAK磷酸化和主动脉环萌芽的生物活性成分。我们的结果为使用PVE治疗周围血管功能不全提供了理论依据;他们表明有必要在PVE组分中鉴定新型促血管生成化学物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号